PLAT and congestive heart failure: After multivariate analysis, after adjusting for race, hypertension, congestive heart failure, liver disease, diabetes, anti-platelet agents, anti-coagulation agents, intravenous tissue plasminogen activator or endovascular mechanical thrombectomy, no differences in ICU mortality (adjusted HR, 0.95; 95% CI, 0.64–1.42), in-hospital mortality (adjusted HR, 1.08; 95% CI, 0.79–1.47).